Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement.
Publication
, Journal Article
Chiong, W; Tolchin, BD; Bonnie, RJ; Busl, K; Cruz-Flores, S; Epstein, LG; Greene, EP; Illes, J; Kirschen, M; Larriviere, DG; Mantri, S ...
Published in: Neurology
November 17, 2021
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
November 17, 2021
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Chiong, W., Tolchin, B. D., Bonnie, R. J., Busl, K., Cruz-Flores, S., Epstein, L. G., … Ethics, Law, and Humanities Committee (a joint committee of the AAN, ANA, and CNS), . (2021). Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement. Neurology. https://doi.org/10.1212/WNL.0000000000013053
Chiong, Winston, Benjamin David Tolchin, Richard J. Bonnie, Katharina Busl, Salvador Cruz-Flores, Leon G. Epstein, Ericka P. Greene, et al. “Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement.” Neurology, November 17, 2021. https://doi.org/10.1212/WNL.0000000000013053.
Chiong W, Tolchin BD, Bonnie RJ, Busl K, Cruz-Flores S, Epstein LG, et al. Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement. Neurology. 2021 Nov 17;
Chiong, Winston, et al. “Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement.” Neurology, Nov. 2021. Pubmed, doi:10.1212/WNL.0000000000013053.
Chiong W, Tolchin BD, Bonnie RJ, Busl K, Cruz-Flores S, Epstein LG, Greene EP, Illes J, Kirschen M, Larriviere DG, Mantri S, Rubin MA, Stern BJ, Taylor LP, Ethics, Law, and Humanities Committee (a joint committee of the AAN, ANA, and CNS). Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement. Neurology. 2021 Nov 17;
Published In
Neurology
DOI
EISSN
1526-632X
Publication Date
November 17, 2021
Location
United States
Related Subject Headings
- Neurology & Neurosurgery
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences